Curbing spending on prescription drugs

Millions of patients suffering from painful and chronic medical conditions could find it easier to access effective and more affordable treatment options, as federal health officials take steps to grow a nascent prescription drug sector known as biosimilars. For Rhode Island, which spends a greater percentage of its gross state product on health care than…

You must be a subscriber to read this content. To keep reading and receive unlimited access subscribe today for only $1.
Subscribe Now Already a Subscriber? Login now

Purchase NowWant to share this story? Click Here to purchase a link that allows anyone to read it on any device whether or not they are a subscriber.